Concentra Reports Strong Q1 2026 Earnings with Double-Digit Revenue and EPS Growth, Continues Share Buyback and Dividends
Summary
Concentra reported strong Q1 2026 financial results with significant revenue and EPS growth, alongside continued share repurchases and dividend payments, while maintaining a healthy balance sheet.
Key Events
-
Strong Q1 2026 Financial Performance
Revenue increased by 13.7% to $569.6 million, net income attributable to the company grew by 29.7% to $50.5 million, and basic EPS rose by 30% to $0.39 compared to Q1 2025. Adjusted EBITDA also increased by 17.6% to $120.7 million.
-
Continued Share Repurchase Program
The company repurchased 0.7 million shares of common stock for $15.0 million during Q1 2026 under its $100 million program, with $65.0 million remaining authorized as of March 31, 2026.
-
Regular Cash Dividend Declared
A cash dividend of $0.0625 per share was declared on May 5, 2026, payable on June 9, 2026, following a similar dividend paid in March 2026.
-
Healthy Liquidity and Leverage
Concentra reported $61.7 million in cash and $434.2 million in available capacity under its revolving credit facility as of March 31, 2026. The company's leverage ratio of 3.4x remains well below the covenant limit of 6.5x.
Analysis
Concentra Group Holdings Parent, Inc. delivered robust financial results for the first quarter of 2026, demonstrating significant operational strength. The company achieved double-digit growth in revenue, net income, and EPS, driven by organic increases in patient visits and revenue per visit, as well as contributions from prior acquisitions. This strong performance is further supported by a healthy liquidity position and a favorable leverage ratio. The company continued its capital return strategy by repurchasing shares under its existing program and declaring a regular cash dividend. While several legal proceedings and investigations are ongoing, the company maintains that it cannot predict their outcome and, for the data breach, does not anticipate a material impact on operations or financial performance, consistent with prior disclosures.
At the time of this filing, CON was trading at $24.70 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $3B. The 52-week trading range was $18.55 to $24.69. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.